Richard Gallagher

Dr. Richard Gallagher

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
HAHoward Abikoff
Howard Abikoff
RGRichard Gallagher
Richard Gallagher
KWKaren C. Wells
Karen C. Wells
DMDesiree W. Murray
Desiree W. Murray
LHLei Huang
Lei Huang
EPEva Petkova
Eva Petkova
The study compared the efficacy of 2 behavioral interventions to ameliorate organization, time management, and planning (OTMP) difficulties in 3rd- to 5th-grade children with attention-deficit/hyperactivity disorder (ADHD). In a dual-site randomized controlled trial, 158 children were assigned to organizational skills training (OST; N = 64); PATHKO, a performance-based intervention that precluded skills training (N = 61); or a wait-list control (WL, N = 33). Treatments were 20 individual clinic-based sessions over 10-12 weeks. OST involved skills building provided primarily to the child. PATHKO trained parents and teachers to reinforce children contingently for meeting end-point target goals. Primary outcomes were the Children's Organizational Skills Scales (COSS-Parent, COSS-Teacher). Other relevant functional outcomes were assessed. Percentage of participants no longer meeting inclusion criteria for OTMP impairments informed on clinical significance. Assessments occurred at post-treatment, 1-month post-treatment, and twice in the following school year. OST was superior to WL on the COSS-P (Cohen's d = 2.77; p < .0001), COSS-T (d = 1.18; p < .0001), children's COSS self-ratings, academic performance and proficiency, homework, and family functioning. OST was significantly better than PATHKO only on the COSS-P (d = 0.63; p < .005). PATHKO was superior to WL on most outcomes but not on academic proficiency. Sixty percent of OST and PATHKO participants versus 3% of controls no longer met OTMP inclusion criteria. Significant maintenance effects were found for both treatments. Two distinct treatments targeting OTMP problems in children with ADHD generated robust, sustained functional improvements. The interventions show promise of clinical utility in children with ADHD and organizational deficits.

1 July 2004 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
HAHoward Abikoff
Howard Abikoff
LHLily Hechtman
Lily Hechtman
RKRachel G. Klein
Rachel G. Klein
RGRichard Gallagher
Richard Gallagher
KFKaren Fleiss
Karen Fleiss
SPSimcha Pollack
Simcha Pollack

1 February 2002 in Journal of Traumatic Stress
Verified
Journal Article
Closed access
PDF file
HKHarold S. Koplewicz
Harold S. Koplewicz
JVJuliet M. Vogel
Juliet M. Vogel
MSMary V. Solanto
Mary V. Solanto
RMRichard F. Morrissey
Richard F. Morrissey
CACarmen M. Alonso
Carmen M. Alonso
RNRona M. Novick
Rona M. Novick

12 March 2008 in Family Process
Verified
Journal Article
Closed access
PDF file
JBJean‐Marie Bruzzese
Jean‐Marie Bruzzese
LULynne Unikel
Lynne Unikel
RGRichard Gallagher
Richard Gallagher
DEDavid Evans
David Evans
VCVivian Colland
Vivian Colland

1 February 2009 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
HAHoward Abikoff
Howard Abikoff
JNJenelle Nissley-Tsiopinis
Jenelle Nissley-Tsiopinis
RGRichard Gallagher
Richard Gallagher
MZMaurizio Zambenedetti
Maurizio Zambenedetti
MSMichael Seyffert
Michael Seyffert
JMJohn McCarthy
John McCarthy

2 January 2021 in Evidence-Based Practice in Child and Adolescent Mental Health
Verified
Journal Article
Closed access
SESteven W. Evans
Steven W. Evans
TBTheodore P. Beauchaine
Theodore P. Beauchaine
ACAndrea Chronis-Tuscano
Andrea Chronis-Tuscano
SBStephen P. Becker
Stephen P. Becker
ACAnil Chacko
Anil Chacko
Eric A. YoungstromEric A. Youngstrom
Eric A. Youngstrom
News of a videogame that received FDA clearance to treat youth with attention-deficit hyperactivity disorder (ADHD) garnered a great deal of media attention and raised questions about the role of digital cognitive training programs for treatment. In order for clinicians and clients to understand this news for the purposes of making treatment decisions one must have an understanding of what it means for a treatment to be considered evidence-based and an understanding of what is required to obtain FDA clearance. Finally, in order to fully inform decisions about treatment, clinicians and parents must be able to consider the evidence supporting cognitive training programs in relation to other treatments available for children with ADHD. A review of these standards and the evidence supporting cognitive training in general, and the new videogame that received recent FDA clearance (EndeavorRXTM) specifically, revealed an overall lack of support for this approach to treatment. There are multiple psychosocial and pharmacological treatment options with much more evidence supporting their effectiveness than any commercially available cognitive training program. The contrast between receiving FDA clearance without evidence of any observable benefits to the child is explained within a description of the FDA process for clearance and approval. Finally, these conclusions are described in the context of clinicians’ decisions regarding services offered and procedures for explaining this to families who may have seen the media attention related to FDA clearance.